Brief: UCB Completes $1.15 Bln Acquisition Of Neurona Therapeutics
BRIEF-UCB Completes $1.15 Bln Acquisition Of Neurona Therapeutics June 2 (Reuters) - Ucb SA UCB.BR:
COMPLETES ACQUISITION OF NEURONA THERAPEUTICS
TOTAL TRANSACTION IS VALUED AT UP TO US $1.15B CONSISTING OF A US $650M UPFRONT PAYMENT PLUS UP TO US $500M IN POTENTIAL FUTURE MILESTONE PAYMENTS
CONFIRMS ITS 2026 FINANCIAL GUIDANCE
Source text: ID:nNDL9bNsTl
Further company coverage: UCB.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;;))
Recent news on UCB SA
See all newsEurope Research Roundup: Banca Generali, Ferrari, Prysmian
Barclays downgrades UCB after rally, sees limited upside
Brief: UCB Says CIMZIA Delivered Consistent Effect In Rheumatoid Arthritis
Brief: UCB Said Dapirolizumab Pegol Shows Potential To Reduce Flare Rates
Brief: UCB Presents Bimzelx Data At Eular 2026